Key Developments

On March 18, 2024, Intuitive Surgical, a medical device company, announced that it had received an approval from the U.S. Food and Drug Administration for its da Vinci Xi system, a next-generation surgical robotics system
On February 21, 2024, Medical Microinstruments, Inc., a developer of a robotic system, announced that that it raised US$ 110 million in a Series C financing round led Fidelity Management & Research Company to help commercialize its surgical robot. The company plans to use the funds to support the commercialization of its Symani surgical system in high-growth markets.
In November 2022, CMR Surgical, a U.K.-based surgical robotics company, announced a collaboration agreement with Ethicon, a subsidiary company of Johnson & Johnson Services, Inc., to expand choice across surgical robotics and advanced laparoscopic instruments. The targeted collaboration agreement will focus on select private hospitals in Italy, France, Germany, and Brazil and will enable Ethicon and CMR commercial teams to offer specific hospitals the advantages of their complementary portfolios together.
In June 2022, SpineGuard, an innovative company that deploys its Dynamic Surgical Guidance (DSG) sensing technology to secure and streamline the placement of bone implants, announced a new three-year collaboration program with two labs of Sorbonne University Centre National de la Recherche Scientifique (CNRS) and Inserm: the ISIR (Institute for intelligent systems and robotics), a multidisciplinary research laboratory, and Laboratory for biomedical imaging (LIB). This collaboration will associate the DSG Technology of SpineGuard with ultrasound and serve surgical robots.